Similar Papers

Paper Title
Journal
Date
Author
The Tolerability and Efficacy of Rapid Infliximab Infusions in Patients with Inflammatory Bowel Disease
Taha Qazi ... Bhavesh Shah
Digestive Diseases and Sciences | VOL. 61
Taha Qazi, et. al.Taha Qazi ... Bhavesh Shah
06 Oct 2015
Transitioning patients with inflammatory bowel disease from hospital-based to rapid home-based infliximab: A stepwise, safety and patient-orientated process towards sustainability.
Anuj Bohra ... Qurat-Al-Ain Rizvi
World Journal of Gastroenterology | VOL. 26
Anuj Bohra, et. al.Anuj Bohra ... Qurat-Al-Ain Rizvi
28 Sep 2020
Rapid Infliximab Infusion in Children with Inflammatory Bowel Disease: A Multicenter North American Experience.
Wael El-Matary ... Charles M Samson
Inflammatory bowel diseases | VOL. 23
Wael El-Matary, et. al.Wael El-Matary ... Charles M Samson
01 Dec 2017
P673 The safety of rapid versus standard infliximab infusions in children with inflammatory bowel disease: a multi-centre retrospective cohort study
J Jagt ... N De Boer
Journal of Crohn's and Colitis | VOL. 17
J Jagt, et. al.J Jagt ... N De Boer
30 Jan 2023
View more papers

More From: Inflammatory Bowel Diseases

Paper Title
Journal
Date
Author
Serum Periostin is Able to Stratify Type 2-Dominant Ulcerative Colitis.
Hironobu Takedomi ... Kenji Izuhara
Inflammatory bowel diseases | VOL. -
Hironobu Takedomi, et. al.Hironobu Takedomi ... Kenji Izuhara
27 Jan 2025
Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA®), for the Prevention of Recurrent Clostridioides difficile Infection in Participants With Inflammatory Bowel Disease in PUNCH CD3-OLS.
Jessica R Allegretti ... Sahil Khanna
Inflammatory bowel diseases | VOL. -
Jessica R Allegretti, et. al.Jessica R Allegretti ... Sahil Khanna
25 Jan 2025
Circulating and Magnetic Resonance Imaging Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's Disease.
Jonathan R Dillman ... Lee A Denson
Inflammatory bowel diseases | VOL. -
Jonathan R Dillman, et. al.Jonathan R Dillman ... Lee A Denson
24 Jan 2025
Inflammation-Induced Th17 Cells Synergize with the Inflammation-Trained Microbiota to Mediate Host Resiliency Against Intestinal Injury.
Jonathan L Golob ... Shrinivas Bishu
Inflammatory bowel diseases | VOL. -
Jonathan L Golob, et. al.Jonathan L Golob ... Shrinivas Bishu
23 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.